128 related articles for article (PubMed ID: 9113339)
1. Studies on duocarmycin SA and its derivatives.
Nagamura S; Asai A; Kobayashi E; Gomi K; Saito H
Bioorg Med Chem; 1997 Mar; 5(3):623-30. PubMed ID: 9113339
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antitumor activity of duocarmycin derivatives: A-ring pyrrole compounds bearing cinnamoyl groups.
Nagamura S; Asai A; Amishiro N; Kobayashi E; Gomi K; Saito H
J Med Chem; 1997 Mar; 40(6):972-9. PubMed ID: 9083487
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antitumor activity of duocarmycin derivatives: A-ring pyrrole analogues of duocarmycin B2.
Nagamura S; Kobayashi E; Gomi K; Saito H
Bioorg Med Chem; 1996 Aug; 4(8):1379-91. PubMed ID: 8879561
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antitumor activity of duocarmycin derivatives.
Nagamura S; Kanda Y; Kobayashi E; Gomi K; Saito H
Chem Pharm Bull (Tokyo); 1995 Sep; 43(9):1530-5. PubMed ID: 7586077
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antitumor activity of duocarmycin derivatives: modification of segment A of duocarmycin B2.
Nagamura S; Asai A; Kanda Y; Kobayashi E; Gomi K; Saito H
Chem Pharm Bull (Tokyo); 1996 Sep; 44(9):1723-30. PubMed ID: 8855367
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antitumor activity of duocarmycin derivatives: A-ring pyrrole compounds bearing beta-(5',6',7'-trimethoxy-2'-indolyl)acryloyl group.
Amishiro N; Nagamura S; Kobayashi E; Okamoto A; Gomi K; Okabe M; Saito H
Bioorg Med Chem; 2000 Jul; 8(7):1637-43. PubMed ID: 10976511
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antitumor activity of duocarmycin derivatives: modification at C-8 position of A-ring pyrrole compounds bearing the simplified DNA-binding groups.
Amishiro N; Nagamura S; Murakata C; Okamoto A; Kobayashi E; Asada M; Gomi K; Tamaoki T; Okabe M; Yamaguchi N; Yamaguchi K; Saito H
Bioorg Med Chem; 2000 Feb; 8(2):381-91. PubMed ID: 10722161
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antitumor activity of duocarmycin derivatives: a-ring pyrrole compounds bearing 5-membered heteroarylacryloyl groups.
Amishiro N; Nagamura S; Kobayashi E; Okamoto A; Gomi K; Saito H
Chem Pharm Bull (Tokyo); 1999 Oct; 47(10):1393-403. PubMed ID: 10553637
[TBL] [Abstract][Full Text] [Related]
9. Bifunctional alkylating agents derived from duocarmycin SA: potent antitumor activity with altered sequence selectivity.
Boger DL; Searcey M; Tse WC; Jin Q
Bioorg Med Chem Lett; 2000 Mar; 10(5):495-8. PubMed ID: 10743956
[TBL] [Abstract][Full Text] [Related]
10. New water-soluble duocarmycin derivatives: synthesis and antitumor activity of A-ring pyrrole compounds bearing beta-heteroarylacryloyl groups.
Amishiro N; Nagamura S; Kobayashi E; Gomi K; Saito H
J Med Chem; 1999 Feb; 42(4):669-76. PubMed ID: 10052974
[TBL] [Abstract][Full Text] [Related]
11. Interconversion and stability of duocarmycins, a new family of antitumor antibiotics: correlation to their cytotoxic and antimicrobial activities in vitro.
Ichimura M; Ogawa T; Takahashi K; Mihara A; Takahashi I; Nakano H
Oncol Res; 1993; 5(4-5):165-71. PubMed ID: 8305742
[TBL] [Abstract][Full Text] [Related]
12. Duocarmycins--natures prodrugs?
Searcey M
Curr Pharm Des; 2002; 8(15):1375-89. PubMed ID: 12052214
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, chemical properties, and biological evaluation of CC-1065 and duocarmycin analogues incorporating the 5-methoxycarbonyl-1,2,9,9a-tetrahydrocyclopropa.
Boger DL; Hughes TV; Hedrick MP
J Org Chem; 2001 Apr; 66(7):2207-16. PubMed ID: 11281757
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antitumor activity of duocarmycin derivatives: modification at the C-7 position of segment-A of A-ring pyrrole compounds.
Amishiro N; Okamoto A; Okabe M; Saito H
Bioorg Med Chem; 2000 May; 8(5):1195-201. PubMed ID: 10882029
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of antitumor activity of KW-2189, a novel water-soluble derivative of duocarmycin, against murine and human tumors.
Kobayashi E; Okamoto A; Asada M; Okabe M; Nagamura S; Asai A; Saito H; Gomi K; Hirata T
Cancer Res; 1994 May; 54(9):2404-10. PubMed ID: 8162588
[TBL] [Abstract][Full Text] [Related]
16. Efficient guanine alkylation through cooperative heterodimeric formation of duocarmycin A and distamycin A.
Isomura M; Sugiyama H; Saito I
Nucleic Acids Symp Ser; 1995; (34):47-8. PubMed ID: 8841545
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antitumor activity of water-soluble duocarmycin B1 prodrugs.
Asai A; Nagamura S; Kobayashi E; Gomi K; Saito H
Bioorg Med Chem Lett; 1999 Oct; 9(20):2995-8. PubMed ID: 10571162
[TBL] [Abstract][Full Text] [Related]
18. Duocarmycin SA, a new antitumor antibiotic from Streptomyces sp.
Ichimura M; Ogawa T; Takahashi K; Kobayashi E; Kawamoto I; Yasuzawa T; Takahashi I; Nakano H
J Antibiot (Tokyo); 1990 Aug; 43(8):1037-8. PubMed ID: 2211354
[No Abstract] [Full Text] [Related]
19. Synthesis and evaluation of a thio analogue of duocarmycin SA.
MacMillan KS; Lajiness JP; Cara CL; Romagnoli R; Robertson WM; Hwang I; Baraldi PG; Boger DL
Bioorg Med Chem Lett; 2009 Dec; 19(24):6962-5. PubMed ID: 19879753
[TBL] [Abstract][Full Text] [Related]
20. Structure of duocarmycin SA, a potent antitumor antibiotic.
Yasuzawa T; Saitoh Y; Ichimura M; Takahashi I; Sano H
J Antibiot (Tokyo); 1991 Apr; 44(4):445-7. PubMed ID: 2032952
[No Abstract] [Full Text] [Related]
[Next] [New Search]
